Arizona State University’s Biodesign C building was recently awarded as the national Best of the Best Project in the Higher Education/Research category by ENR (Engineering News Record), a publication focusing on engineering and construction news. Approximately 200 projects were considered for the honor, spanning 10 regions across America.Continue reading
Learn more about the seed grant program and about the Mayo Clinic and Arizona State University Alliance for Health Care.
But what if researchers designed a tractable, powered exoskeleton that assists with upper-extremity function? What if it could be controlled by users’ own brains, responding directly to their intentions and gradually reducing assistance as they gain strength?
Such a design is just what Thomas Sugar, a professor at Arizona State University’s Polytechnic School, and Kenton Kaufman, a professor of biomedical engineering at Mayo Clinic, have proposed. Their project is one of eight innovative pilot studies that will be explored through the 2019 Mayo Clinic and Arizona State University seed grant program.
Since 2005, Mayo Clinic and ASU have provided seed funding to new, interdisciplinary and translational joint research projects. By launching novel research on a small scale, researchers have been able to attract funding needed for larger studies that may make a significant impact in their fields and improve patient care.
Each research team includes one researcher from ASU and one from Mayo Clinic. The projects draw on the strengths of each institution.
“The seed grants are symbolic of the synergy between ASU and Mayo Clinic in clinical research,” said Hugo Vargas, medical director of Mayo Clinic’s Office of Clinical Research in Arizona. “The commitment of both institutions to innovate in health care technology and delivery has been a fixture since the inception of the seed grants in 2005. This collaborative effort allows team development between ASU and all three of the Mayo Clinic campuses. The awards aim to capitalize on the strengths of each institution and the evidence points to growth of medical research to the benefit of patients in the respective communities.”
“We are delighted to support the researchers as they work to develop their ideas in a collaborative manner to improve patient outcomes,” said Cheryl Conrad, assistant vice president of research development for the ASU Knowledge Enterprise. “By capitalizing on each team member’s clinical expertise and a commitment to innovative research, ASU and Mayo Clinic are addressing important issues in health and medicine.”
From 2005 through 2017, the Mayo Clinic and ASU seed grants have translated into 57 externally funded projects worth approximately $30.5 million. Seed grant recipients have also shared their knowledge through more than 25 journal publications and by mentoring student researchers.
2019 seed grant projects and lead investigators
“Novel minimally invasive device to induce weight loss”
Junseok Chae, School of Electrical, Computer and Energy Engineering, ASU
Rahmi Oklu, MD, PhD, Radiology, Mayo Clinic
“Integrating genomic and imaging biomarkers for early detection of Alzheimer’s disease”
Yalin Wang, School of Computing, Informatics, and Decision Systems Engineering, ASU
Junwen Wang, PhD, Research, Mayo Clinic
“Bioinspired electrospun fibrous patch for augmenting rotator cuff repair”
Julianne Holloway, School for Engineering of Matter, Transport and Energy, ASU
John Tokish, MD, Orthopedic Surgery, Mayo Clinic
“Myoelectrically controlled power-assist upper-extremity exoskeleton”
Thomas Sugar, Polytechnic School, ASU
Kenton Kaufman, PhD, Orthopedic Surgery, Mayo Clinic
“Interaction between pancreatic triglyceride lipase (PNLIP) and its selective inhibitor”
Matthew D. Green, School for Engineering of Matter, Transport and Energy, ASU
Vijay P. Singh, MD, Center for Clinical and Translational Science, Mayo Clinic
“Promoting efficient muscle repair in Duchenne muscular dystrophy patients”
Alan Rawls, School of Life Sciences, ASU
Elizabeth Jacobsen, PhD, Internal Medicine, Mayo Clinic
“Impact of the extracellular vesicle glycome on brain metastasis”
Chad Borges, School of Molecular Sciences and the Biodesign Institute, ASU
Joy Wolfram, PhD, Mayo Clinic
“Quantifying mitochondrial metabolites to define the role of mitochondria in stem cell function and fate”
Haiwei Gu, College of Health Solutions, ASU
Clifford Folmes, PhD, Department of Cardiovascular Diseases, Mayo Clinic
Learn more about the seed grant program and about the Mayo Clinic and Arizona State University Alliance for Health Care. If you are an ASU researcher, sign up to receive notifications about funding opportunities.
PHOENIX, AZ—January 18, 2018 – The Arizona Health Care Cost Containment System (AHCCCS) received 1115 Waiver Amendment approval from the Centers for Medicare and Medicaid Services (CMS) to implement community engagement requirements for some able bodied AHCCCS members ages 19 to 49, and to limit retroactive coverage for some applicants to the beginning of the month in which the Medicaid application is filed. Continue reading
New technology allows better tracking of potentially deadly infectionContinue reading
Chief Executive Officer TJ Johnson to assume role of Executive Chairman at the end of first quarter 2019
John Lubniewski, President and Chief Operating Officer, appointed as successorContinue reading
Researchers at the University of Arizona have discovered a protein that prevents mosquitoes from hatching, opening the possibility of developing new drugs that could act as birth control for mosquito populations.Continue reading
Critical Path Institute (C-Path) and Flagstaff, Arizona-based TGen North — the Pathogen and Microbiome Division of the Translational Genomics Research Institute (TGen) — have received a Phase 1 Concept Validation grant from the Flinn Foundation, of $400,000 over 12 months, to develop and pilot a framework enabling the state institutions to be more responsive to antimicrobial resistance. Working as partners in this venture, C-Path and TGen, an affiliate of City of Hope, will solidify requirements among multiple stakeholders and develop an integrated deployment plan for a statewide Healthcare Associated Antimicrobial Resistant Microbe genomic surveillance system, dubbed Prevent HAARM.Continue reading
In a new study, researchers at the Biodesign Institute explore a safe and simple treatment for one of the most devastating and perplexing afflictions: Alzheimer’s disease.Continue reading